Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN
September 12, 2024 08:00 ET
|
Vera Therapeutics
On track to announce topline results from ORIGIN 3 trial in Q2 2025Expect to present 96-week data from ORIGIN Phase 2b clinical trial of atacicept in IgAN in Q4 2024 BRISBANE, Calif., Sept. 12,...
Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference
September 12, 2024 08:00 ET
|
Keros Therapeutics, Inc.
LEXINGTON, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...
PetMed Express, Inc. Announces Appointment of Robyn D’Elia as Chief Financial Officer
September 12, 2024 08:00 ET
|
PetMed Express, Inc.
DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company") today announced the appointment of retail and...
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
September 12, 2024 08:00 ET
|
Daxor Corporation
Review Published in the Prestigious Journal Cardiorenal Medicine Oak Ridge, TN, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...
MasterCraft Agrees to Sell Merritt Island Boat Manufacturing Plant
September 12, 2024 08:00 ET
|
MasterCraft Boat Holdings, Inc.
VONORE, Tenn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”), today announced that it has entered into an agreement to sell its boat manufacturing...
Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders’ Meeting
September 12, 2024 08:00 ET
|
Sharps Technology Inc
NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: STSS and STSSW) (“Sharps Technology” or the “Company”), an innovative medical device and pharmaceutical packaging...
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference
September 12, 2024 08:00 ET
|
Solid Biosciences Inc.
CHARLESTOWN, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for...
Kratos Announces Immediate Availability of TDI’s Four Classes of Low-Cost Turbojet Engines
September 12, 2024 08:00 ET
|
Kratos Defense & Security Solutions, Inc.
SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, today announced...
Intellia Therapeutics to Present Data from the Phase 2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the 2024 ACAAI Annual Scientific Meeting
September 12, 2024 07:30 ET
|
Intellia Therapeutics, Inc.
First presentation of detailed Phase 2 results following previous positive topline announcement that study of NTLA-2002 met primary and all secondary endpoints Intellia to host investor webcast on...
Biogen Board Appoints Two New Independent Directors
September 12, 2024 07:30 ET
|
Biogen Inc.
CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- The Biogen Inc. (Nasdaq: BIIB) Board of Directors (the “Board”) today announced the appointments of two new independent directors, Lloyd B....